ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ACell enters Chinese distribution agreement for wound management
April 09, 2019Weihai Jierui gets exclusive rights for sale, marketing, and distribution of ACell's devices in mainland China and Hong Kong, S.A.R., China for 10 years after marketing clearance -
ACell enters distribution agreement for wound management
March 20, 2019ACell, Inc. a leading regenerative medicine company, has recently announced that it has entered into an exclusive distribution agreement with MyungMoon Bio Co. Ltd. MyungMoon is a leading manufacturer and distributor of medical devices and pharmaceutical -
Smith & Nephew buys Osiris in regenerative medicine push
March 14, 2019Medical equipment company Smith & Nephew has agreed a $660 million deal to buy US biotech Osiris Therapeutics that expands its business into regenerative medicine.
Pharma Sources Insight January 2025
